Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Hepatic Veno Occlusive Disease

fluorodeoxyglucose f18 has been researched along with Hepatic Veno Occlusive Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedossa, P; Bozec, L; Gauthé, M1
Baek, SE; Cho, A; Kim, H; Lee, N; Moon, J; Roh, YH1
Habu, D; Hayashi, T; Kawabe, J; Kawamura, E; Kotani, J; Oe, A; Sakaguchi, H; Shiomi, S; Torii, K1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Hepatic Veno Occlusive Disease

ArticleYear
Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: report of two cases treated by defibrotide.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:5

    Topics: Adult; Fibrinolytic Agents; Fluorodeoxyglucose F18; Hepatic Veno-Occlusive Disease; Humans; Male; Middle Aged; Polydeoxyribonucleotides; Positron-Emission Tomography; Radiopharmaceuticals

2014
Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome.
    Oncotarget, 2016, 10-18, Volume: 7, Issue:42

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Hepatic Veno-Occlusive Disease; Humans; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Count; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome

2016
A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET.
    Annals of nuclear medicine, 2005, Volume: 19, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Hepatic Veno-Occlusive Disease; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals

2005